nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA2—stomach cancer	0.456	1	CbGaD
Zoledronate—ABCC1—Epirubicin—stomach cancer	0.0759	0.268	CbGbCtD
Zoledronate—ABCC1—Irinotecan—stomach cancer	0.0738	0.261	CbGbCtD
Zoledronate—ABCC1—Docetaxel—stomach cancer	0.0541	0.191	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—stomach cancer	0.0403	0.142	CbGbCtD
Zoledronate—ABCC1—Methotrexate—stomach cancer	0.0391	0.138	CbGbCtD
Zoledronate—GGPS1—hematopoietic system—stomach cancer	0.00348	0.1	CbGeAlD
Zoledronate—GGPS1—lymphoid tissue—stomach cancer	0.00245	0.0705	CbGeAlD
Zoledronate—GGPS1—bone marrow—stomach cancer	0.00223	0.0642	CbGeAlD
Zoledronate—GGPS1—endocrine gland—stomach cancer	0.002	0.0576	CbGeAlD
Zoledronate—GGPS1—liver—stomach cancer	0.0018	0.0519	CbGeAlD
Zoledronate—FDPS—hematopoietic system—stomach cancer	0.00161	0.0462	CbGeAlD
Zoledronate—CA2—gall bladder—stomach cancer	0.00147	0.0424	CbGeAlD
Zoledronate—FDPS—smooth muscle tissue—stomach cancer	0.00141	0.0407	CbGeAlD
Zoledronate—GGPS1—lymph node—stomach cancer	0.00138	0.0398	CbGeAlD
Zoledronate—FDPS—pancreas—stomach cancer	0.00131	0.0376	CbGeAlD
Zoledronate—FDPS—lymphoid tissue—stomach cancer	0.00113	0.0325	CbGeAlD
Zoledronate—CA12—digestive system—stomach cancer	0.00113	0.0325	CbGeAlD
Zoledronate—FDPS—digestive system—stomach cancer	0.00112	0.0321	CbGeAlD
Zoledronate—CA14—liver—stomach cancer	0.00108	0.031	CbGeAlD
Zoledronate—FDPS—bone marrow—stomach cancer	0.00103	0.0296	CbGeAlD
Zoledronate—CA12—endocrine gland—stomach cancer	0.000933	0.0268	CbGeAlD
Zoledronate—FDPS—endocrine gland—stomach cancer	0.000923	0.0265	CbGeAlD
Zoledronate—CA2—hematopoietic system—stomach cancer	0.000833	0.024	CbGeAlD
Zoledronate—FDPS—liver—stomach cancer	0.000832	0.0239	CbGeAlD
Zoledronate—CA2—epithelium—stomach cancer	0.000762	0.0219	CbGeAlD
Zoledronate—CA2—smooth muscle tissue—stomach cancer	0.000734	0.0211	CbGeAlD
Zoledronate—CA2—pancreas—stomach cancer	0.000679	0.0195	CbGeAlD
Zoledronate—FDPS—lymph node—stomach cancer	0.000638	0.0183	CbGeAlD
Zoledronate—CA2—lymphoid tissue—stomach cancer	0.000587	0.0169	CbGeAlD
Zoledronate—CA2—digestive system—stomach cancer	0.00058	0.0167	CbGeAlD
Zoledronate—CA2—bone marrow—stomach cancer	0.000534	0.0154	CbGeAlD
Zoledronate—ABCC1—liver—stomach cancer	0.000483	0.0139	CbGeAlD
Zoledronate—CA2—endocrine gland—stomach cancer	0.000479	0.0138	CbGeAlD
Zoledronate—CA2—liver—stomach cancer	0.000432	0.0124	CbGeAlD
Zoledronate—Risedronate—PTGS2—stomach cancer	0.00043	0.529	CrCbGaD
Zoledronate—Clodronate—PTGS2—stomach cancer	0.000383	0.471	CrCbGaD
Zoledronate—ABCC1—lymph node—stomach cancer	0.00037	0.0107	CbGeAlD
Zoledronate—CA2—lymph node—stomach cancer	0.000331	0.00952	CbGeAlD
Zoledronate—Musculoskeletal discomfort—Capecitabine—stomach cancer	8.05e-05	0.000538	CcSEcCtD
Zoledronate—Cardiac disorder—Epirubicin—stomach cancer	8.04e-05	0.000538	CcSEcCtD
Zoledronate—Flushing—Epirubicin—stomach cancer	8.04e-05	0.000538	CcSEcCtD
Zoledronate—Vomiting—Fluorouracil—stomach cancer	8.04e-05	0.000537	CcSEcCtD
Zoledronate—Dyspepsia—Docetaxel—stomach cancer	8.03e-05	0.000537	CcSEcCtD
Zoledronate—Insomnia—Capecitabine—stomach cancer	7.99e-05	0.000534	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—stomach cancer	7.97e-05	0.000533	CcSEcCtD
Zoledronate—Rash—Fluorouracil—stomach cancer	7.97e-05	0.000533	CcSEcCtD
Zoledronate—Dermatitis—Fluorouracil—stomach cancer	7.96e-05	0.000532	CcSEcCtD
Zoledronate—FDPS—Metabolism—ECHS1—stomach cancer	7.95e-05	0.00106	CbGpPWpGaD
Zoledronate—Paraesthesia—Capecitabine—stomach cancer	7.93e-05	0.00053	CcSEcCtD
Zoledronate—Decreased appetite—Docetaxel—stomach cancer	7.93e-05	0.00053	CcSEcCtD
Zoledronate—Headache—Fluorouracil—stomach cancer	7.92e-05	0.00053	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—stomach cancer	7.91e-05	0.000529	CcSEcCtD
Zoledronate—CA14—Metabolism—RORA—stomach cancer	7.91e-05	0.00105	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—TYMS—stomach cancer	7.91e-05	0.00105	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	7.9e-05	0.00105	CbGpPWpGaD
Zoledronate—Oedema peripheral—Doxorubicin—stomach cancer	7.89e-05	0.000528	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—stomach cancer	7.89e-05	0.000528	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Docetaxel—stomach cancer	7.88e-05	0.000527	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—stomach cancer	7.87e-05	0.000527	CcSEcCtD
Zoledronate—Dyspnoea—Capecitabine—stomach cancer	7.87e-05	0.000527	CcSEcCtD
Zoledronate—Fatigue—Docetaxel—stomach cancer	7.86e-05	0.000526	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—stomach cancer	7.86e-05	0.000525	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—stomach cancer	7.86e-05	0.000525	CcSEcCtD
Zoledronate—Nausea—Irinotecan—stomach cancer	7.84e-05	0.000524	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—stomach cancer	7.82e-05	0.000523	CcSEcCtD
Zoledronate—GGPS1—Metabolism—GSTM1—stomach cancer	7.82e-05	0.00104	CbGpPWpGaD
Zoledronate—Mediastinal disorder—Epirubicin—stomach cancer	7.81e-05	0.000522	CcSEcCtD
Zoledronate—Pain—Docetaxel—stomach cancer	7.8e-05	0.000522	CcSEcCtD
Zoledronate—Constipation—Docetaxel—stomach cancer	7.8e-05	0.000522	CcSEcCtD
Zoledronate—Back pain—Methotrexate—stomach cancer	7.79e-05	0.000521	CcSEcCtD
Zoledronate—Dyspepsia—Capecitabine—stomach cancer	7.77e-05	0.00052	CcSEcCtD
Zoledronate—Chills—Epirubicin—stomach cancer	7.77e-05	0.00052	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—stomach cancer	7.74e-05	0.000517	CcSEcCtD
Zoledronate—CA2—Metabolism—FBP1—stomach cancer	7.73e-05	0.00103	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NDUFA2—stomach cancer	7.73e-05	0.00103	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CKB—stomach cancer	7.73e-05	0.00103	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CA1—stomach cancer	7.73e-05	0.00103	CbGpPWpGaD
Zoledronate—Decreased appetite—Capecitabine—stomach cancer	7.68e-05	0.000513	CcSEcCtD
Zoledronate—CA12—Metabolism—PDHA1—stomach cancer	7.67e-05	0.00102	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ECHS1—stomach cancer	7.67e-05	0.00102	CbGpPWpGaD
Zoledronate—Alopecia—Epirubicin—stomach cancer	7.65e-05	0.000512	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Capecitabine—stomach cancer	7.63e-05	0.00051	CcSEcCtD
Zoledronate—Fatigue—Capecitabine—stomach cancer	7.61e-05	0.000509	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—stomach cancer	7.59e-05	0.000508	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—stomach cancer	7.59e-05	0.000507	CcSEcCtD
Zoledronate—Pain—Capecitabine—stomach cancer	7.55e-05	0.000505	CcSEcCtD
Zoledronate—Constipation—Capecitabine—stomach cancer	7.55e-05	0.000505	CcSEcCtD
Zoledronate—Erythema—Epirubicin—stomach cancer	7.54e-05	0.000504	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—stomach cancer	7.54e-05	0.000504	CcSEcCtD
Zoledronate—Feeling abnormal—Docetaxel—stomach cancer	7.52e-05	0.000503	CcSEcCtD
Zoledronate—Nausea—Fluorouracil—stomach cancer	7.51e-05	0.000502	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—stomach cancer	7.49e-05	0.000501	CcSEcCtD
Zoledronate—FDPS—Metabolism—FADS1—stomach cancer	7.48e-05	0.000993	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TYMP—stomach cancer	7.48e-05	0.000993	CbGpPWpGaD
Zoledronate—Ill-defined disorder—Methotrexate—stomach cancer	7.47e-05	0.0005	CcSEcCtD
Zoledronate—Gastrointestinal pain—Docetaxel—stomach cancer	7.46e-05	0.000499	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—stomach cancer	7.45e-05	0.000498	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—stomach cancer	7.44e-05	0.000497	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—stomach cancer	7.44e-05	0.000497	CcSEcCtD
Zoledronate—CA14—Metabolism—ALDOB—stomach cancer	7.42e-05	0.000985	CbGpPWpGaD
Zoledronate—Dysgeusia—Epirubicin—stomach cancer	7.38e-05	0.000494	CcSEcCtD
Zoledronate—GGPS1—Metabolism—ERCC2—stomach cancer	7.35e-05	0.000977	CbGpPWpGaD
Zoledronate—Back pain—Epirubicin—stomach cancer	7.29e-05	0.000488	CcSEcCtD
Zoledronate—Feeling abnormal—Capecitabine—stomach cancer	7.28e-05	0.000487	CcSEcCtD
Zoledronate—CA2—Metabolism—PLIN2—stomach cancer	7.27e-05	0.000966	CbGpPWpGaD
Zoledronate—Angiopathy—Doxorubicin—stomach cancer	7.27e-05	0.000486	CcSEcCtD
Zoledronate—Malaise—Methotrexate—stomach cancer	7.27e-05	0.000486	CcSEcCtD
Zoledronate—Muscle spasms—Epirubicin—stomach cancer	7.25e-05	0.000485	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—stomach cancer	7.24e-05	0.000484	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—stomach cancer	7.24e-05	0.000484	CcSEcCtD
Zoledronate—Gastrointestinal pain—Capecitabine—stomach cancer	7.22e-05	0.000483	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—stomach cancer	7.22e-05	0.000483	CcSEcCtD
Zoledronate—Abdominal pain—Docetaxel—stomach cancer	7.21e-05	0.000482	CcSEcCtD
Zoledronate—Body temperature increased—Docetaxel—stomach cancer	7.21e-05	0.000482	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—stomach cancer	7.21e-05	0.000482	CcSEcCtD
Zoledronate—CA12—Metabolism—FADS1—stomach cancer	7.21e-05	0.000957	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TYMP—stomach cancer	7.21e-05	0.000957	CbGpPWpGaD
Zoledronate—Chills—Doxorubicin—stomach cancer	7.19e-05	0.000481	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—stomach cancer	7.16e-05	0.000479	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—stomach cancer	7.11e-05	0.000475	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—stomach cancer	7.08e-05	0.000474	CcSEcCtD
Zoledronate—Cough—Methotrexate—stomach cancer	7.03e-05	0.00047	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—stomach cancer	7.02e-05	0.00047	CcSEcCtD
Zoledronate—Urticaria—Capecitabine—stomach cancer	7.02e-05	0.000469	CcSEcCtD
Zoledronate—FDPS—Metabolism—SREBF2—stomach cancer	7e-05	0.00093	CbGpPWpGaD
Zoledronate—Ill-defined disorder—Epirubicin—stomach cancer	7e-05	0.000468	CcSEcCtD
Zoledronate—Abdominal pain—Capecitabine—stomach cancer	6.98e-05	0.000467	CcSEcCtD
Zoledronate—Body temperature increased—Capecitabine—stomach cancer	6.98e-05	0.000467	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—stomach cancer	6.98e-05	0.000467	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—stomach cancer	6.98e-05	0.000467	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—stomach cancer	6.98e-05	0.000467	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—stomach cancer	6.97e-05	0.000466	CcSEcCtD
Zoledronate—Agitation—Epirubicin—stomach cancer	6.93e-05	0.000463	CcSEcCtD
Zoledronate—FDPS—Metabolism—RORA—stomach cancer	6.92e-05	0.000919	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—MTHFR—stomach cancer	6.91e-05	0.000918	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PGAM1—stomach cancer	6.89e-05	0.000916	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALOX5—stomach cancer	6.89e-05	0.000916	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NT5E—stomach cancer	6.89e-05	0.000916	CbGpPWpGaD
Zoledronate—Myalgia—Methotrexate—stomach cancer	6.86e-05	0.000459	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—stomach cancer	6.86e-05	0.000459	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—stomach cancer	6.86e-05	0.000459	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—stomach cancer	6.83e-05	0.000457	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	6.81e-05	0.000456	CcSEcCtD
Zoledronate—Malaise—Epirubicin—stomach cancer	6.8e-05	0.000455	CcSEcCtD
Zoledronate—CA14—Metabolism—DPYD—stomach cancer	6.78e-05	0.000901	CbGpPWpGaD
Zoledronate—Discomfort—Methotrexate—stomach cancer	6.78e-05	0.000453	CcSEcCtD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—stomach cancer	6.78e-05	0.0009	CbGpPWpGaD
Zoledronate—Vertigo—Epirubicin—stomach cancer	6.77e-05	0.000453	CcSEcCtD
Zoledronate—Syncope—Epirubicin—stomach cancer	6.76e-05	0.000452	CcSEcCtD
Zoledronate—CA12—Metabolism—SREBF2—stomach cancer	6.75e-05	0.000896	CbGpPWpGaD
Zoledronate—Leukopenia—Epirubicin—stomach cancer	6.75e-05	0.000451	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—stomach cancer	6.75e-05	0.000451	CcSEcCtD
Zoledronate—Hypersensitivity—Docetaxel—stomach cancer	6.72e-05	0.000449	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—stomach cancer	6.71e-05	0.000449	CcSEcCtD
Zoledronate—CA12—Metabolism—RORA—stomach cancer	6.67e-05	0.000886	CbGpPWpGaD
Zoledronate—Palpitations—Epirubicin—stomach cancer	6.66e-05	0.000446	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—stomach cancer	6.63e-05	0.000443	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—stomach cancer	6.63e-05	0.000443	CcSEcCtD
Zoledronate—Cough—Epirubicin—stomach cancer	6.58e-05	0.00044	CcSEcCtD
Zoledronate—CA2—Metabolism—PLCE1—stomach cancer	6.58e-05	0.000873	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALDH7A1—stomach cancer	6.58e-05	0.000873	CbGpPWpGaD
Zoledronate—Anaphylactic shock—Methotrexate—stomach cancer	6.57e-05	0.00044	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—stomach cancer	6.57e-05	0.00044	CcSEcCtD
Zoledronate—Asthenia—Docetaxel—stomach cancer	6.55e-05	0.000438	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—stomach cancer	6.53e-05	0.000437	CcSEcCtD
Zoledronate—Infection—Methotrexate—stomach cancer	6.53e-05	0.000437	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ACAD8—stomach cancer	6.52e-05	0.000866	CbGpPWpGaD
Zoledronate—Hypertension—Epirubicin—stomach cancer	6.51e-05	0.000435	CcSEcCtD
Zoledronate—Hypersensitivity—Capecitabine—stomach cancer	6.51e-05	0.000435	CcSEcCtD
Zoledronate—FDPS—Metabolism—ALDOB—stomach cancer	6.48e-05	0.000861	CbGpPWpGaD
Zoledronate—Ill-defined disorder—Doxorubicin—stomach cancer	6.47e-05	0.000433	CcSEcCtD
Zoledronate—Pruritus—Docetaxel—stomach cancer	6.45e-05	0.000432	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—stomach cancer	6.45e-05	0.000431	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—stomach cancer	6.45e-05	0.000431	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—stomach cancer	6.44e-05	0.000431	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—stomach cancer	6.42e-05	0.000429	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—stomach cancer	6.42e-05	0.000429	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—stomach cancer	6.42e-05	0.000429	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—stomach cancer	6.41e-05	0.000429	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—stomach cancer	6.4e-05	0.000428	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—stomach cancer	6.39e-05	0.000427	CcSEcCtD
Zoledronate—GGPS1—Metabolism—CAV1—stomach cancer	6.38e-05	0.000847	CbGpPWpGaD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	6.37e-05	0.000426	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	6.37e-05	0.000846	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—APOA1—stomach cancer	6.36e-05	0.000845	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Methotrexate—stomach cancer	6.36e-05	0.000425	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—stomach cancer	6.34e-05	0.000424	CcSEcCtD
Zoledronate—Asthenia—Capecitabine—stomach cancer	6.34e-05	0.000424	CcSEcCtD
Zoledronate—CA2—Metabolism—UMPS—stomach cancer	6.31e-05	0.000837	CbGpPWpGaD
Zoledronate—Malaise—Doxorubicin—stomach cancer	6.29e-05	0.000421	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—stomach cancer	6.28e-05	0.00042	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—stomach cancer	6.27e-05	0.000419	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—stomach cancer	6.27e-05	0.000419	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—stomach cancer	6.26e-05	0.000418	CcSEcCtD
Zoledronate—CA12—Metabolism—ALDOB—stomach cancer	6.25e-05	0.00083	CbGpPWpGaD
Zoledronate—Pruritus—Capecitabine—stomach cancer	6.25e-05	0.000418	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—stomach cancer	6.24e-05	0.000418	CcSEcCtD
Zoledronate—Diarrhoea—Docetaxel—stomach cancer	6.24e-05	0.000417	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—stomach cancer	6.2e-05	0.000415	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—stomach cancer	6.16e-05	0.000412	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—stomach cancer	6.15e-05	0.000411	CcSEcCtD
Zoledronate—Oedema—Epirubicin—stomach cancer	6.15e-05	0.000411	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—stomach cancer	6.14e-05	0.000411	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—stomach cancer	6.13e-05	0.00041	CcSEcCtD
Zoledronate—Infection—Epirubicin—stomach cancer	6.11e-05	0.000409	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.11e-05	0.000812	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.1e-05	0.00081	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.09e-05	0.000809	CbGpPWpGaD
Zoledronate—Cough—Doxorubicin—stomach cancer	6.09e-05	0.000407	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.06e-05	0.000805	CbGpPWpGaD
Zoledronate—Shock—Epirubicin—stomach cancer	6.05e-05	0.000405	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—stomach cancer	6.04e-05	0.000404	CcSEcCtD
Zoledronate—Diarrhoea—Capecitabine—stomach cancer	6.04e-05	0.000404	CcSEcCtD
Zoledronate—Nervous system disorder—Epirubicin—stomach cancer	6.03e-05	0.000404	CcSEcCtD
Zoledronate—Dizziness—Docetaxel—stomach cancer	6.03e-05	0.000403	CcSEcCtD
Zoledronate—FDPS—Metabolism—ALOX5—stomach cancer	6.03e-05	0.0008	CbGpPWpGaD
Zoledronate—Thrombocytopenia—Epirubicin—stomach cancer	6.02e-05	0.000403	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—stomach cancer	6.02e-05	0.000403	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—stomach cancer	6.01e-05	0.000402	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTT1—stomach cancer	6e-05	0.000796	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	5.99e-05	0.000796	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Methotrexate—stomach cancer	5.99e-05	0.000401	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—stomach cancer	5.98e-05	0.0004	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—stomach cancer	5.95e-05	0.000398	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—stomach cancer	5.95e-05	0.000398	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—stomach cancer	5.94e-05	0.000397	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—stomach cancer	5.94e-05	0.000397	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—stomach cancer	5.94e-05	0.000397	CcSEcCtD
Zoledronate—CA14—Metabolism—CYP2A6—stomach cancer	5.93e-05	0.000787	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—DPYD—stomach cancer	5.93e-05	0.000787	CbGpPWpGaD
Zoledronate—Anxiety—Doxorubicin—stomach cancer	5.92e-05	0.000396	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—stomach cancer	5.9e-05	0.000395	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	5.9e-05	0.000394	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—stomach cancer	5.87e-05	0.000392	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—stomach cancer	5.87e-05	0.000392	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—stomach cancer	5.86e-05	0.000392	CcSEcCtD
Zoledronate—CA2—Metabolism—PDHA1—stomach cancer	5.86e-05	0.000778	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ECHS1—stomach cancer	5.86e-05	0.000778	CbGpPWpGaD
Zoledronate—Somnolence—Methotrexate—stomach cancer	5.85e-05	0.000391	CcSEcCtD
Zoledronate—Dizziness—Capecitabine—stomach cancer	5.84e-05	0.000391	CcSEcCtD
Zoledronate—CA12—Metabolism—ALOX5—stomach cancer	5.81e-05	0.000772	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GMPR2—stomach cancer	5.81e-05	0.000772	CbGpPWpGaD
Zoledronate—Dry mouth—Doxorubicin—stomach cancer	5.81e-05	0.000388	CcSEcCtD
Zoledronate—Vomiting—Docetaxel—stomach cancer	5.8e-05	0.000388	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—stomach cancer	5.79e-05	0.000387	CcSEcCtD
Zoledronate—CA14—Metabolism—AKR1C3—stomach cancer	5.77e-05	0.000766	CbGpPWpGaD
Zoledronate—Rash—Docetaxel—stomach cancer	5.75e-05	0.000385	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—stomach cancer	5.75e-05	0.000385	CcSEcCtD
Zoledronate—Dermatitis—Docetaxel—stomach cancer	5.75e-05	0.000384	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—stomach cancer	5.74e-05	0.000384	CcSEcCtD
Zoledronate—CA12—Metabolism—DPYD—stomach cancer	5.72e-05	0.000759	CbGpPWpGaD
Zoledronate—Decreased appetite—Methotrexate—stomach cancer	5.72e-05	0.000382	CcSEcCtD
Zoledronate—Headache—Docetaxel—stomach cancer	5.71e-05	0.000382	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—stomach cancer	5.69e-05	0.000381	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—stomach cancer	5.69e-05	0.000381	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—stomach cancer	5.68e-05	0.00038	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—stomach cancer	5.67e-05	0.000379	CcSEcCtD
Zoledronate—Infection—Doxorubicin—stomach cancer	5.66e-05	0.000378	CcSEcCtD
Zoledronate—Pain—Methotrexate—stomach cancer	5.62e-05	0.000376	CcSEcCtD
Zoledronate—CA14—Metabolism—ENO1—stomach cancer	5.62e-05	0.000746	CbGpPWpGaD
Zoledronate—Vomiting—Capecitabine—stomach cancer	5.62e-05	0.000376	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	5.61e-05	0.000745	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Epirubicin—stomach cancer	5.61e-05	0.000375	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PPARG—stomach cancer	5.61e-05	0.000744	CbGpPWpGaD
Zoledronate—Shock—Doxorubicin—stomach cancer	5.6e-05	0.000375	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—stomach cancer	5.58e-05	0.000373	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—stomach cancer	5.57e-05	0.000373	CcSEcCtD
Zoledronate—Rash—Capecitabine—stomach cancer	5.57e-05	0.000372	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—stomach cancer	5.57e-05	0.000372	CcSEcCtD
Zoledronate—Dermatitis—Capecitabine—stomach cancer	5.56e-05	0.000372	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—stomach cancer	5.56e-05	0.000372	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	5.54e-05	0.000736	CbGpPWpGaD
Zoledronate—Headache—Capecitabine—stomach cancer	5.53e-05	0.00037	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—stomach cancer	5.53e-05	0.00037	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—stomach cancer	5.53e-05	0.00037	CcSEcCtD
Zoledronate—CA2—Metabolism—FADS1—stomach cancer	5.51e-05	0.000732	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TYMP—stomach cancer	5.51e-05	0.000732	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Doxorubicin—stomach cancer	5.5e-05	0.000368	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—stomach cancer	5.49e-05	0.000367	CcSEcCtD
Zoledronate—Somnolence—Epirubicin—stomach cancer	5.47e-05	0.000366	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—stomach cancer	5.43e-05	0.000363	CcSEcCtD
Zoledronate—Nausea—Docetaxel—stomach cancer	5.42e-05	0.000362	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—stomach cancer	5.42e-05	0.000362	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—stomach cancer	5.42e-05	0.000362	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—stomach cancer	5.38e-05	0.00036	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.37e-05	0.000714	CbGpPWpGaD
Zoledronate—Decreased appetite—Epirubicin—stomach cancer	5.35e-05	0.000358	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—stomach cancer	5.32e-05	0.000356	CcSEcCtD
Zoledronate—ABCC1—Metabolism—SUCLG1—stomach cancer	5.31e-05	0.000706	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—IDH3B—stomach cancer	5.31e-05	0.000706	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Epirubicin—stomach cancer	5.31e-05	0.000355	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—stomach cancer	5.3e-05	0.000355	CcSEcCtD
Zoledronate—Constipation—Epirubicin—stomach cancer	5.26e-05	0.000352	CcSEcCtD
Zoledronate—Pain—Epirubicin—stomach cancer	5.26e-05	0.000352	CcSEcCtD
Zoledronate—ABCC1—Disease—PGLS—stomach cancer	5.26e-05	0.000698	CbGpPWpGaD
Zoledronate—Nausea—Capecitabine—stomach cancer	5.25e-05	0.000351	CcSEcCtD
Zoledronate—FDPS—Metabolism—GSTT1—stomach cancer	5.24e-05	0.000696	CbGpPWpGaD
Zoledronate—Urticaria—Methotrexate—stomach cancer	5.22e-05	0.000349	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—stomach cancer	5.2e-05	0.000348	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—stomach cancer	5.2e-05	0.000348	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.19e-05	0.000347	CcSEcCtD
Zoledronate—FDPS—Metabolism—CYP2A6—stomach cancer	5.18e-05	0.000688	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SREBF2—stomach cancer	5.16e-05	0.000685	CbGpPWpGaD
Zoledronate—Insomnia—Doxorubicin—stomach cancer	5.15e-05	0.000344	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—stomach cancer	5.11e-05	0.000342	CcSEcCtD
Zoledronate—CA2—Metabolism—RORA—stomach cancer	5.1e-05	0.000677	CbGpPWpGaD
Zoledronate—Dyspnoea—Doxorubicin—stomach cancer	5.08e-05	0.000339	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—stomach cancer	5.07e-05	0.000339	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—stomach cancer	5.06e-05	0.000338	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTT1—stomach cancer	5.05e-05	0.000671	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKR1C3—stomach cancer	5.04e-05	0.000669	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ALB—stomach cancer	5.04e-05	0.000669	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Epirubicin—stomach cancer	5.03e-05	0.000336	CcSEcCtD
Zoledronate—ABCC1—Disease—RBP1—stomach cancer	5.02e-05	0.000666	CbGpPWpGaD
Zoledronate—Dyspepsia—Doxorubicin—stomach cancer	5.01e-05	0.000335	CcSEcCtD
Zoledronate—CA12—Metabolism—CYP2A6—stomach cancer	5e-05	0.000664	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CD44—stomach cancer	4.98e-05	0.000662	CbGpPWpGaD
Zoledronate—Decreased appetite—Doxorubicin—stomach cancer	4.95e-05	0.000331	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NDUFS1—stomach cancer	4.94e-05	0.000656	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NDUFV1—stomach cancer	4.94e-05	0.000656	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.92e-05	0.000329	CcSEcCtD
Zoledronate—FDPS—Metabolism—ENO1—stomach cancer	4.91e-05	0.000652	CbGpPWpGaD
Zoledronate—Fatigue—Doxorubicin—stomach cancer	4.91e-05	0.000328	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—stomach cancer	4.89e-05	0.000327	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—stomach cancer	4.87e-05	0.000326	CcSEcCtD
Zoledronate—Pain—Doxorubicin—stomach cancer	4.87e-05	0.000326	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—stomach cancer	4.86e-05	0.000325	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—stomach cancer	4.86e-05	0.000325	CcSEcCtD
Zoledronate—CA12—Metabolism—AKR1C3—stomach cancer	4.86e-05	0.000645	CbGpPWpGaD
Zoledronate—Hypersensitivity—Methotrexate—stomach cancer	4.84e-05	0.000324	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.83e-05	0.000642	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	4.83e-05	0.000641	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—NOS3—stomach cancer	4.82e-05	0.00064	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALDOB—stomach cancer	4.78e-05	0.000635	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ENO1—stomach cancer	4.74e-05	0.000629	CbGpPWpGaD
Zoledronate—Asthenia—Methotrexate—stomach cancer	4.72e-05	0.000315	CcSEcCtD
Zoledronate—Feeling abnormal—Doxorubicin—stomach cancer	4.69e-05	0.000314	CcSEcCtD
Zoledronate—Gastrointestinal pain—Doxorubicin—stomach cancer	4.66e-05	0.000311	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—stomach cancer	4.65e-05	0.000311	CcSEcCtD
Zoledronate—Hypersensitivity—Epirubicin—stomach cancer	4.53e-05	0.000303	CcSEcCtD
Zoledronate—Urticaria—Doxorubicin—stomach cancer	4.52e-05	0.000302	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—stomach cancer	4.5e-05	0.000301	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—stomach cancer	4.5e-05	0.000301	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—stomach cancer	4.5e-05	0.000301	CcSEcCtD
Zoledronate—ABCC1—Disease—FBP1—stomach cancer	4.47e-05	0.000594	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALOX5—stomach cancer	4.44e-05	0.00059	CbGpPWpGaD
Zoledronate—Asthenia—Epirubicin—stomach cancer	4.41e-05	0.000295	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PTGS2—stomach cancer	4.41e-05	0.000586	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PGLS—stomach cancer	4.4e-05	0.000585	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BLVRB—stomach cancer	4.4e-05	0.000585	CbGpPWpGaD
Zoledronate—CA2—Metabolism—DPYD—stomach cancer	4.37e-05	0.00058	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CD44—stomach cancer	4.36e-05	0.000579	CbGpPWpGaD
Zoledronate—Pruritus—Epirubicin—stomach cancer	4.35e-05	0.000291	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—stomach cancer	4.35e-05	0.000291	CcSEcCtD
Zoledronate—CA14—Metabolism—PPP2R1A—stomach cancer	4.24e-05	0.000563	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.23e-05	0.000561	CbGpPWpGaD
Zoledronate—Diarrhoea—Epirubicin—stomach cancer	4.21e-05	0.000282	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PPAP2A—stomach cancer	4.2e-05	0.000558	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CD44—stomach cancer	4.2e-05	0.000558	CbGpPWpGaD
Zoledronate—Hypersensitivity—Doxorubicin—stomach cancer	4.19e-05	0.000281	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—stomach cancer	4.18e-05	0.00028	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTP1—stomach cancer	4.16e-05	0.000552	CbGpPWpGaD
Zoledronate—Rash—Methotrexate—stomach cancer	4.15e-05	0.000277	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—stomach cancer	4.14e-05	0.000277	CcSEcCtD
Zoledronate—Headache—Methotrexate—stomach cancer	4.12e-05	0.000275	CcSEcCtD
Zoledronate—CA14—Metabolism—HMOX1—stomach cancer	4.1e-05	0.000544	CbGpPWpGaD
Zoledronate—Asthenia—Doxorubicin—stomach cancer	4.08e-05	0.000273	CcSEcCtD
Zoledronate—Dizziness—Epirubicin—stomach cancer	4.07e-05	0.000272	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.04e-05	0.000536	CbGpPWpGaD
Zoledronate—Pruritus—Doxorubicin—stomach cancer	4.03e-05	0.000269	CcSEcCtD
Zoledronate—ABCC1—Disease—PGAM1—stomach cancer	3.98e-05	0.000529	CbGpPWpGaD
Zoledronate—Vomiting—Epirubicin—stomach cancer	3.91e-05	0.000262	CcSEcCtD
Zoledronate—Nausea—Methotrexate—stomach cancer	3.91e-05	0.000261	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—stomach cancer	3.9e-05	0.000261	CcSEcCtD
Zoledronate—Rash—Epirubicin—stomach cancer	3.88e-05	0.000259	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—stomach cancer	3.88e-05	0.000259	CcSEcCtD
Zoledronate—CA2—Metabolism—GSTT1—stomach cancer	3.86e-05	0.000513	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TYMS—stomach cancer	3.86e-05	0.000513	CbGpPWpGaD
Zoledronate—Headache—Epirubicin—stomach cancer	3.85e-05	0.000258	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP2A6—stomach cancer	3.82e-05	0.000507	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTM1—stomach cancer	3.82e-05	0.000507	CbGpPWpGaD
Zoledronate—ABCC1—Disease—WIF1—stomach cancer	3.8e-05	0.000505	CbGpPWpGaD
Zoledronate—Dizziness—Doxorubicin—stomach cancer	3.76e-05	0.000252	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CKB—stomach cancer	3.74e-05	0.000497	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NDUFA2—stomach cancer	3.74e-05	0.000497	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA1—stomach cancer	3.74e-05	0.000497	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FBP1—stomach cancer	3.74e-05	0.000497	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKR1C3—stomach cancer	3.72e-05	0.000493	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPP2R1A—stomach cancer	3.7e-05	0.000492	CbGpPWpGaD
Zoledronate—Nausea—Epirubicin—stomach cancer	3.65e-05	0.000244	CcSEcCtD
Zoledronate—FDPS—Metabolism—GSTP1—stomach cancer	3.63e-05	0.000483	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ENO1—stomach cancer	3.62e-05	0.000481	CbGpPWpGaD
Zoledronate—Vomiting—Doxorubicin—stomach cancer	3.62e-05	0.000242	CcSEcCtD
Zoledronate—CA14—Metabolism—ERCC2—stomach cancer	3.59e-05	0.000477	CbGpPWpGaD
Zoledronate—Rash—Doxorubicin—stomach cancer	3.59e-05	0.00024	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—stomach cancer	3.59e-05	0.00024	CcSEcCtD
Zoledronate—FDPS—Metabolism—HMOX1—stomach cancer	3.58e-05	0.000476	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL13—stomach cancer	3.57e-05	0.000475	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL18—stomach cancer	3.57e-05	0.000475	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPP2R1A—stomach cancer	3.57e-05	0.000474	CbGpPWpGaD
Zoledronate—Headache—Doxorubicin—stomach cancer	3.57e-05	0.000239	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PLIN2—stomach cancer	3.52e-05	0.000467	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTP1—stomach cancer	3.5e-05	0.000465	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMOX1—stomach cancer	3.46e-05	0.000459	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA2—stomach cancer	3.42e-05	0.000455	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RNF43—stomach cancer	3.39e-05	0.00045	CbGpPWpGaD
Zoledronate—Nausea—Doxorubicin—stomach cancer	3.38e-05	0.000226	CcSEcCtD
Zoledronate—FDPS—Metabolism—TYMS—stomach cancer	3.38e-05	0.000449	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MTHFR—stomach cancer	3.38e-05	0.000448	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—stomach cancer	3.34e-05	0.000443	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NT5E—stomach cancer	3.34e-05	0.000443	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PGAM1—stomach cancer	3.34e-05	0.000443	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS21—stomach cancer	3.33e-05	0.000443	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS15—stomach cancer	3.33e-05	0.000443	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TYMS—stomach cancer	3.26e-05	0.000433	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTM1—stomach cancer	3.22e-05	0.000428	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CD44—stomach cancer	3.21e-05	0.000427	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDH7A1—stomach cancer	3.18e-05	0.000423	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLCE1—stomach cancer	3.18e-05	0.000423	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ERCC2—stomach cancer	3.14e-05	0.000417	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CAV1—stomach cancer	3.11e-05	0.000414	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOA1—stomach cancer	3.11e-05	0.000413	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UMPS—stomach cancer	3.05e-05	0.000405	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ERCC2—stomach cancer	3.03e-05	0.000402	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—stomach cancer	2.95e-05	0.000392	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—stomach cancer	2.85e-05	0.000378	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PDHA1—stomach cancer	2.84e-05	0.000377	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ECHS1—stomach cancer	2.84e-05	0.000377	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ALDOB—stomach cancer	2.76e-05	0.000367	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—stomach cancer	2.74e-05	0.000364	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPP2R1A—stomach cancer	2.73e-05	0.000363	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.73e-05	0.000363	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAV1—stomach cancer	2.72e-05	0.000361	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOA1—stomach cancer	2.72e-05	0.000361	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—stomach cancer	2.71e-05	0.00036	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL15—stomach cancer	2.71e-05	0.00036	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—stomach cancer	2.68e-05	0.000356	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TYMP—stomach cancer	2.67e-05	0.000354	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FADS1—stomach cancer	2.67e-05	0.000354	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NPM1—stomach cancer	2.66e-05	0.000353	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMOX1—stomach cancer	2.64e-05	0.000351	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAV1—stomach cancer	2.62e-05	0.000349	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOA1—stomach cancer	2.62e-05	0.000348	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.6e-05	0.000345	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RBP4—stomach cancer	2.57e-05	0.000341	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS26—stomach cancer	2.53e-05	0.000335	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPIA—stomach cancer	2.51e-05	0.000333	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SREBF2—stomach cancer	2.5e-05	0.000332	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TYMS—stomach cancer	2.49e-05	0.000331	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—RORA—stomach cancer	2.47e-05	0.000328	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—stomach cancer	2.46e-05	0.000327	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—stomach cancer	2.46e-05	0.000327	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—stomach cancer	2.39e-05	0.000318	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NOS3—stomach cancer	2.35e-05	0.000313	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ERCC2—stomach cancer	2.31e-05	0.000307	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDOB—stomach cancer	2.31e-05	0.000307	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—stomach cancer	2.31e-05	0.000306	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.18e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.18e-05	0.000289	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—stomach cancer	2.18e-05	0.000289	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—stomach cancer	2.15e-05	0.000286	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—stomach cancer	2.15e-05	0.000286	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALOX5—stomach cancer	2.15e-05	0.000286	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKR1C3—stomach cancer	2.15e-05	0.000285	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS19—stomach cancer	2.15e-05	0.000285	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—DPYD—stomach cancer	2.12e-05	0.000281	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ENO1—stomach cancer	2.09e-05	0.000278	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—stomach cancer	2.07e-05	0.000276	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.07e-05	0.000275	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NOS3—stomach cancer	2.06e-05	0.000273	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—stomach cancer	2.01e-05	0.000266	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA1—stomach cancer	2e-05	0.000266	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—stomach cancer	1.98e-05	0.000264	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.92e-05	0.000255	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS6—stomach cancer	1.9e-05	0.000252	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—stomach cancer	1.88e-05	0.00025	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—stomach cancer	1.87e-05	0.000248	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD44—stomach cancer	1.86e-05	0.000247	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2A6—stomach cancer	1.85e-05	0.000246	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—stomach cancer	1.82e-05	0.000241	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C3—stomach cancer	1.8e-05	0.000239	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—stomach cancer	1.76e-05	0.000234	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ENO1—stomach cancer	1.75e-05	0.000233	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HBEGF—stomach cancer	1.75e-05	0.000232	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.72e-05	0.000229	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—stomach cancer	1.64e-05	0.000218	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—stomach cancer	1.59e-05	0.000211	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPP2R1A—stomach cancer	1.58e-05	0.00021	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CD44—stomach cancer	1.55e-05	0.000206	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—stomach cancer	1.52e-05	0.000202	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.51e-05	0.0002	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SMAD4—stomach cancer	1.47e-05	0.000195	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FYN—stomach cancer	1.39e-05	0.000185	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—stomach cancer	1.39e-05	0.000184	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERCC2—stomach cancer	1.34e-05	0.000178	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—stomach cancer	1.32e-05	0.000176	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPP2R1A—stomach cancer	1.32e-05	0.000176	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR2—stomach cancer	1.31e-05	0.000173	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—stomach cancer	1.3e-05	0.000172	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—stomach cancer	1.28e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—stomach cancer	1.26e-05	0.000167	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TYMS—stomach cancer	1.21e-05	0.00016	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS2—stomach cancer	1.2e-05	0.000159	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—stomach cancer	1.19e-05	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—stomach cancer	1.16e-05	0.000154	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—stomach cancer	1.16e-05	0.000154	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA1—stomach cancer	1.16e-05	0.000154	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ERCC2—stomach cancer	1.12e-05	0.000149	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—stomach cancer	1.12e-05	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6ST—stomach cancer	1.1e-05	0.000146	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—stomach cancer	1.06e-05	0.00014	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—stomach cancer	1.05e-05	0.00014	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6R—stomach cancer	9.81e-06	0.00013	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—stomach cancer	9.71e-06	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA1—stomach cancer	9.69e-06	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.28e-06	0.000123	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—stomach cancer	9.19e-06	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RHOA—stomach cancer	8.86e-06	0.000118	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—stomach cancer	8.77e-06	0.000116	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—stomach cancer	8.54e-06	0.000113	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—stomach cancer	8.54e-06	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—stomach cancer	8.2e-06	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—stomach cancer	8.02e-06	0.000107	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—stomach cancer	7.68e-06	0.000102	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—stomach cancer	7.6e-06	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—stomach cancer	7.35e-06	9.75e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—stomach cancer	7.01e-06	9.31e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—stomach cancer	6.72e-06	8.92e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—stomach cancer	6.26e-06	8.31e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—stomach cancer	5.98e-06	7.94e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—stomach cancer	5.81e-06	7.72e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK1—stomach cancer	5.69e-06	7.55e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—stomach cancer	5.69e-06	7.55e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—stomach cancer	5.37e-06	7.13e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—stomach cancer	4.94e-06	6.55e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—stomach cancer	4.57e-06	6.06e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—stomach cancer	4.37e-06	5.8e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—stomach cancer	4.13e-06	5.49e-05	CbGpPWpGaD
